- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04142853
Underlying Causes and Related Factors, and Rehabilitation Approaches
Walking-related Performance Fatigabitity in People With Multiple Sclerosis: Clinical Profile o
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Hasselt, Belgio, 3500
- Hasselt University
-
Liège, Belgio, 4000
- Centre Hospitalier Universitaire de Liege
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age between 18 and 70 years.
- MS diagnosis according to McDonald Criteria.
- Capable of walking 6 minutes (independent or with unilateral support) without stopping.
Exclusion Criteria:
- Exacerbation or relapse within last 3 months before study
- Other medical condition interfering with walking ability (e.g. cardiac or respiratory diseases, arthritis and fibromyalgia, stroke, Parkinson).
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Selezione
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Persons with MS, dance group
|
Training intervention + Dance intervention
|
|
Comparatore attivo: Persons with MS, art group
|
Training intervention + Dance intervention
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
il Symbol Digit Modality Test (SDMT) (faticabilità cognitiva)
Lasso di tempo: settimana 11
|
il suo è un test delle prestazioni cognitive, comprovato da attenzione, velocità e scansione visiva.
Le risposte corrette durano 30 secondi rispetto ai primi 30 secondi
|
settimana 11
|
|
Test del piolo a nove fori (NHPT)
Lasso di tempo: settimana 11
|
Si tratta di un test motorio per valutare le abilità manuali del partecipante.
Questo test registra il tempo necessario al partecipante per posizionare 9 birilli nel pannello forato e rimuoverli di nuovo.
|
settimana 11
|
|
the Coordination test
Lasso di tempo: Day 1
|
Participant is seated with legs strapped in to the mounts and moves legs to the beat of a metronome to assess central motor control.
|
Day 1
|
|
TST (Triple Stimulation Technique)
Lasso di tempo: day 3
|
Technique in which nerves are stimulated to check guidance in the central nervous system
|
day 3
|
|
TMS (Transcranial Magnetic Stimulation)
Lasso di tempo: Day 3
|
Technique in which nerves are stimulated to check guidance in the central nervous system
|
Day 3
|
|
the Voluntary Drive test
Lasso di tempo: Day 1
|
The participant is seated in a Biodex.
While performing a leg extension the Quadriceps muscle is stimulated to check the guidance of electrical signals to the muscles.
|
Day 1
|
|
the Fatigability Index Legs
Lasso di tempo: Day 1
|
Participant is seated in a Biodex and a protocol is performed to establish the muscle strength and muscle endurance of the legs.
|
Day 1
|
|
Analysis of a Muscle Biopsy
Lasso di tempo: Day 3
|
A small piece of muscle tissue of the weakest leg will be biopsied and analyzed in the lab.
|
Day 3
|
|
the Digit Span
Lasso di tempo: Baseline
|
Cognitive test where numbers must be recalled in a certain order to evaluate short term memory
|
Baseline
|
|
the Digit Span
Lasso di tempo: Week 11
|
Cognitive test where numbers must be recalled in a certain order to evaluate short term memory
|
Week 11
|
|
the Stroop test
Lasso di tempo: Baseline
|
Cognitive test to evaluate attention and simultaneous processing of multiple stimuli.
|
Baseline
|
|
the Stroop test
Lasso di tempo: week 11
|
Cognitive test to evaluate attention and simultaneous processing of multiple stimuli.
|
week 11
|
|
the Paced Auditory Serial Addition Test (PASAT)
Lasso di tempo: Baseline
|
This is a cognitive test where the participant will try to retain certain numbers they hear and do math.
Correct answer last 1/3 vs first 1/3
|
Baseline
|
|
the Paced Auditory Serial Addition Test (PASAT)
Lasso di tempo: Week 11
|
This is a cognitive test where the participant will try to retain certain numbers they hear and do math.
Correct answer last 1/3 vs first 1/3
|
Week 11
|
|
the Symbol Digit Modality Test (SDMT) (Cognitive fatigability)
Lasso di tempo: Baseline
|
his is a cognitive performance test, substantiated with focus, speed, and visual scanning.
Correct answers last 30 seconds vs first 30 seconds
|
Baseline
|
|
Motor function test (lower limb muscle strength)
Lasso di tempo: Baseline
|
This is a motor test to assess the functional lower limb muscle strength.
The participant is asked to stand from a seated position and sit down again as fast as possible for five times in a row.
|
Baseline
|
|
Motor function test (lower limb muscle strength)
Lasso di tempo: week 11
|
This is a motor test to assess the functional lower limb muscle strength.
The participant is asked to stand from a seated position and sit down again as fast as possible for five times in a row.
|
week 11
|
|
25 Foot Walk (T25FW) test
Lasso di tempo: Baseline
|
his is a motor test at which the participant is instructed to walk 25 ft (=7,62 meter) as fast and safely as possible.
This is a quantitative performance test to assess mobility and leg function.
|
Baseline
|
|
25 Foot Walk (T25FW) test
Lasso di tempo: week 11
|
his is a motor test at which the participant is instructed to walk 25 ft (=7,62 meter) as fast and safely as possible.
This is a quantitative performance test to assess mobility and leg function.
|
week 11
|
|
Nine Hole Peg Test (NHPT)
Lasso di tempo: Baseline
|
This is a motor test to assess the participant's manual skills.
This test records the time the participant needs to place 9 pins in the pegboard and remove them again.
|
Baseline
|
|
Fatigability Index Hand
Lasso di tempo: Baseline
|
Grip strength will be evaluated through a Jamar dynamometer.
|
Baseline
|
|
Fatigability Index Hand
Lasso di tempo: week 11
|
Grip strength will be evaluated through a Jamar dynamometer.
|
week 11
|
|
Activity tracker
Lasso di tempo: Up to 5 days
|
A sensor will be placed around the foot and worn by the participant for 5 days and nights to evaluate physical activity and quality of sleep.
|
Up to 5 days
|
|
Glycocheck
Lasso di tempo: Baseline
|
A small camera will be placed under the tongue of the participant and blood vessels will be filmed to determine the quality of the blood vessels and immunity.
|
Baseline
|
|
Six minute walking test
Lasso di tempo: once during the observational study
|
Participant have to walk as far as they can for 6 minutes.
Total distance walked and fatigability by comparing first and last minute distance will be calculated.
|
once during the observational study
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fatigue severity scale (FSS)
Lasso di tempo: baseline
|
A self-report scale of nine items about fatigue, its severity and how it affects certain activities.
Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree.
This means the minimum score possible is nine and the highest is 63.
The higher the score, the more severe the fatigue is and the more it affects the person's activities.
It is simple to understand and takes an average of eight minutes to answer
|
baseline
|
|
Fatigue severity scale (FSS)
Lasso di tempo: week 11
|
A self-report scale of nine items about fatigue, its severity and how it affects certain activities.
Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree.
This means the minimum score possible is nine and the highest is 63.
The higher the score, the more severe the fatigue is and the more it affects the person's activities.
It is simple to understand and takes an average of eight minutes to answer
|
week 11
|
|
Modified Fatigue Impact Scale (MFIS)
Lasso di tempo: baseline
|
This is a short questionnaire to evaluate to impact of general fatigue.
This questionnaire measures the effects of fatigue on three levels: physical, cognitive and psychosocial.
The MFIS is a 21-item questionaire, scale 0 (never)-4 (always), scale range 0-40
|
baseline
|
|
Modified Fatigue Impact Scale (MFIS)
Lasso di tempo: week 11
|
This is a short questionnaire to evaluate to impact of general fatigue.
This questionnaire measures the effects of fatigue on three levels: physical, cognitive and psychosocial.The MFIS is a 21-item questionaire, scale 0 (never)-4 (always), scale range 0-40
|
week 11
|
|
Fatigue Scale of Motor and Cognitive Functions (FSMC)
Lasso di tempo: baseline
|
This is a short questionnaire to cognitive and motor fatigue in people with MS.
The FSMC is an assessment of MS-related cognitive and motor fatigue.
A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question.
Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).
Two subscales (mental and physical fatigue) can be made.
Items included in the subscale mental are 1-4-7-8-11-13-15-17-18-20 and items included in the subscale physical are 2-3-5-6-9-10-12-14-16-19.
|
baseline
|
|
Fatigue Scale of Motor and Cognitive Functions (FSMC)
Lasso di tempo: week 11
|
This is a short questionnaire to cognitive and motor fatigue in people with MS.
The FSMC is an assessment of MS-related cognitive and motor fatigue.
A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question.
Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).
Two subscales (mental and physical fatigue) can be made.
Items included in the subscale mental are 1-4-7-8-11-13-15-17-18-20 and items included in the subscale physical are 2-3-5-6-9-10-12-14-16-19.
|
week 11
|
|
Hospital Anxiety and Depression Scale (HADS)
Lasso di tempo: baseline
|
This is a short questionnaire that evaluates symptoms of anxiety and depression in daily life.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression..
|
baseline
|
|
Hospital Anxiety and Depression Scale (HADS)
Lasso di tempo: Week 11
|
This is a short questionnaire that evaluates symptoms of anxiety and depression in daily life.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
|
Week 11
|
|
The Sleep Condition Indicator (SCI)
Lasso di tempo: baseline
|
This is a short questionnaire to evaluate sleeping pattern and potential sleeping disorders.
The Sleep Condition Indicator (SCI) is an eight-item rating scale (4-0) that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
baseline
|
|
The Sleep Condition Indicator (SCI)
Lasso di tempo: week 11
|
This is a short questionnaire to evaluate sleeping pattern and potential sleeping disorders.
The Sleep Condition Indicator (SCI) is an eight-item rating scale (4-0) that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
week 11
|
|
Social Role Participation Questionnaire (SRPQ)
Lasso di tempo: baseline
|
This is a short questionnaire to evaluate social participation.
scale 1 (not important) - 5(very important)
|
baseline
|
|
Social Role Participation Questionnaire (SRPQ)
Lasso di tempo: week 11
|
This is a short questionnaire to evaluate social participation.
scale 1 (not important) - 5 (very important)
|
week 11
|
|
pre-interventionMSWS-12 score
Lasso di tempo: baseline
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
baseline
|
|
post-interventionMSWS-12 score
Lasso di tempo: baseline
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
baseline
|
|
pre-interventionMSWS-12 score
Lasso di tempo: week 11
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
week 11
|
|
post-interventionMSWS-12 score
Lasso di tempo: week 11
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
week 11
|
|
Multiple Sclerosis Impact Scale (MSIS-29)
Lasso di tempo: Baseline
|
This is a short self-report questionnaire used to assess the day-to-day life in the past two weeks. This questionnaire has a physical and psychological scale. The MSIS-29 is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). The physical impact score is computed by summing items number 1-20 inclusive. This score can then be transformed to a score on a scale of 0 -100 |
Baseline
|
|
Multiple Sclerosis Impact Scale (MSIS-29)
Lasso di tempo: week 11
|
This is a short self-report questionnaire used to assess the day-to-day life in the past two weeks. This questionnaire has a physical and psychological scale. The MSIS-29 is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). The physical impact score is computed by summing items number 1-20 inclusive. This score can then be transformed to a score on a scale of 0 -100 |
week 11
|
|
Short Form Health survey (SF-36)
Lasso di tempo: Baseline
|
questionnaire to measure health status.
The Optum® SF-36v2® Health Survey asks 36 questions to measure functional health and well-being from the patient's point of view.
It is a practical, reliable and valid measure of physical and mental health that can be completed in five to ten minutes.
|
Baseline
|
|
Short Form Health survey (SF-36)
Lasso di tempo: week 11
|
questionnaire to measure health status.
The Optum® SF-36v2® Health Survey asks 36 questions to measure functional health and well-being from the patient's point of view.
It is a practical, reliable and valid measure of physical and mental health that can be completed in five to ten minutes.
|
week 11
|
Collaboratori e investigatori
Sponsor
Collaboratori
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- B707201835771
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Sclerosi multipla
-
Sanko UniversityCompletatoMULTIPLE SCLEROSIS | BILANCIO | VALIDITÀ | AFFIDABILITÀTurchia (Türkiye)
Prove cliniche su Training intervention + Dance intervention
-
University of ZurichETH Zurich (Switzerland)Reclutamento
-
Superior UniversityAttivo, non reclutanteArtrosi al ginocchioPakistan
-
Oregon Health and Science UniversityNational Institute of Mental Health (NIMH); University of Connecticut; University... e altri collaboratoriNon ancora reclutamento
-
KK Women's and Children's HospitalCompletatoCambio di pesoSingapore
-
Ege Miray TopcuCompletatoAnsia | Terapia di supporto gestita da infermiere | Interventi infermieristiciTurchia (Türkiye)
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD); American...Non ancora reclutamentoIpertensione | Ipertensione complicata con il diabete di tipo 2Stati Uniti
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Virginia Commonwealth UniversityReclutamentoObesità | Cancro | Attività fisica | Dieta | Sopravvivenza al cancroStati Uniti
-
University of PittsburghCompletatoDistrofia muscolare di DuchenneStati Uniti
-
PeriPharmNon ancora reclutamentoEczema | Dermatite atopica | Caregiver | Fardello | Eczema Dermatite Atopica
-
PeriPharmCompletatoLupus | Artrite da lupus | Lupus Artrite, Lupus Eritematoso Sistemico | Qualità della vita (QOL)Canada